ZoomMed
Healthcare Software · New York, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
590 Madison Ave, New York City, New York...Phone Number
(877) 678-5457Website
www.zoommedcorpo.comRevenue
$7.5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About ZoomMed
ZoomMed offers innovative healthcare software solutions, including the ZRx Prescriber, a predictive e-prescribing tool designed to assist physicians in their practice. The company also provides PraxisLab, a platform tailored for pharmacy chains. With a focus on enhancing the efficiency of healthcare providers, ZoomMed has secured distribution rights for Rx Vigilance's Quick Glance in the United States. Their intended clients include physicians, EHR vendors, and pharmacists.Explore more
ZoomMed Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is ZoomMed your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
ZoomMed, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once ZoomMed has new funding data
Congratulate Masked Content for being promoted to Masked Content at ZoomMed
Click to see if ZoomMed had a recent Job posting/layoffs
Earning: See what the market has to say on ZoomMed recently announced quarterly report
Check out if ZoomMed is spiking on competitors!
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when ZoomMed launches new products
Check if ZoomMed has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Find VP level buyers at ZoomMed
Find more new buyers
Compare Similar Companies to ZoomMed
Compare insights from companies similar to ZoomMed, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
ZoomMed is experiencing very low activity levels compared to other companies in the Software sector.
What does this means?
ZoomMed is drawing exceptional interest within the Software industry, suggesting notable developments or strong market momentum, learn more about ZoomMed.
ZoomMed financials insights
Gather financial insights about ZoomMed, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2017
Debt
$500K
ZoomMed Tech Stack
A closer look at the technologies used by ZoomMed
See more technologies
ZoomMed News & Media
ZoomMed sells certain intellectual property rights in its ZRx Prescriber to KDA Group Inc., in exchange of 20,000,000 shares of KDA Group valued at $ 3,140,000
BROSSARD, Quebec, May 11, 2021 (GLOBE NEWSWIRE) -- ZoomMed Inc. (the “Corporation” or “ZoomMed”) (TSX Venture Exchange:ZMD) is proud to announce that the transaction to acquire the intellectual property rights of the ZRx Prescriber to develop, market and operate the ZRx Prescriber in the United States, Europe and the United Kingdom has been completed with the wholly owned subsidiary KDA Technological Group inc. (“KDA Techno”) of the KDA Group inc. ("KDA").Distribution of ZRx Prescriber and KDA Group
MONTREAL, Aug. 28, 2018 (GLOBE NEWSWIRE) -- ZoomMed Inc. (the “Corporation” or “ZoomMed”) (TSX Venture Exchange: ZMD). It is with surprise that the management of ZoomMed has learned that the Board of Directors of KDA Group has refused to issue 10 million Class A Common shares of its share capital to ZoomMed as was promised under the non-exclusive License that was signed on May 31, 2018. Despite obtaining the conditional approval of the TSX VentureZoomMed and KDA Group Join Forces to Distribute the ZRx Prescriber in the United States
MONTREAL, June 01, 2018 (GLOBE NEWSWIRE) -- ZoomMed Inc. (the “Corporation” or “ZoomMed”) (TSX Venture Exchange:ZMD) and KDA Group Inc. (“KDA”) (TSX Venture Exchange:KDA) are proud to announce an agreement whereby Group KDA could distribute under a non-exclusive license the ZRx Prescriber, develop by ZoomMed, in the United States. The Corporation and Group KDA are also expecting to conclude, shortly, a joint venture agreement in order to unite their expertise for the development and commerciali
Read more news
Top Healthcare Software Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding ZoomMed
Sign Up For FreeTo access detailed company insights
ZoomMed offers innovative healthcare software solutions, including the ZRx Prescriber, a predictive e-prescribing tool designed to assist physicians in their practice. The company also provides PraxisLab, a platform tailored for pharmacy chains. With a focus on enhancing the efficiency of healthcare providers, ZoomMed has secured distribution right... Read More
